Suraj Peri

7.4k citations

63 papers · 3.2k indexed · 2 hit papers · h-index 30

Impact in

Hepatology top 2%
- Hepatitis C virus research
Immunology top 5%
- interferon and immune responses

Papers in

Cancer Research 12
Oncology 18
- Cancer Risks and Factors 4

Co-authors: Akhilesh Pandey Siddharth Balachandran Hanno Steen Michael SlifkerTing ZhangChaoran Yin Paul G. Thomas Yan Xu
Journals: Clinical Cancer Research (4 papers)Cancer Research (4 papers)Cancer Prevention Research (3 papers)PLoS ONE (3 papers)Trends in Genetics (2 papers)
Partner nations: United States Denmark India

In The Last Decade

Suraj Peri

63 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis 2022 · 262 citations

Peers

Countries citing papers authored by Suraj Peri

Since Specialization

Citations

This map shows the geographic impact of Suraj Peri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suraj Peri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suraj Peri more than expected).

Fields of papers citing papers by Suraj Peri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suraj Peri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suraj Peri. The network helps show where Suraj Peri may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suraj Peri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suraj Peri Line = papers co-authored together Suraj Peri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints Oncogene ·Maria Chelmińska, Konstantin Budagyan, Cristina Uribe‐Alvarez, Alison Kurimchak, Daniela Araiza‐Olivera, Kathy Q. Cai, Suraj Peri, Yan Zhou, James S. Duncan, Jonathan Chernoff	2024	5
2	ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis Nature ·Ting Zhang, Chaoran Yin, А. И. Федоров, Liangjun Qiao, Hong‐Liang Bao, Nazar Beknazarov, Shiyu Wang, Avishekh Gautam, Riley Williams, Jeremy Chase Crawford, Suraj Peri, Vasily M. Studitsky, Amer A. Beg, Paul G. Thomas, Carl R. Walkley, Yan Xu, Maria Poptsova, Alan Herbert, Siddharth Balachandran Hit paper breakdown →	2022	262
3	Essential role of a ThPOK autoregulatory loop in the maintenance of mature CD4+ T cell identity and function Nature Immunology ·Jayati Basu, Bernardo Sgarbi Reis, Suraj Peri, Jikun Zha, Hua Xiang, Lu Ge, Kyle Ferchen, Émmanuelle Nicolas, Yassine Essakali, Kathy Q. Cai, Yinfei Tan, Juan I. Fuxman Bass, Albertha J.M. Walhout, H. Leighton Grimes, Sergei I. Grivennikov, Daniel Mucida, Dietmar J. Kappes	2021	10
4	Abstract PO-068: Cholesterol auxotrophy promotes the expansion of centroacinar cells giving rise to the basal subtype of pancreatic adenocarcinoma Cancer Research ·Christine Ojala, 治輝奥村, Linara Gabitova, Suraj Peri, Diana Restifo, Kathy Q. Cai, Artem Barski, Igor Astsaturov	2021	1
5	Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma Clinical Cancer Research ·Yinfei Tan, Eleonora Sementino, Mitchell Cheung, Suraj Peri, Craig W. Menges, 茂登代梶谷, Ting Zhang, Vladimir Khazak, 江晓岩, Eric A. Ross, Jirong Xu, Suresh C. Jhanwar, Raja M. Flores, Siddharth Balachandran, Joseph R. Testa	2020	38
6	Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma Science Signaling ·Alison Kurimchak, Tisya Kusuma Rini, 赵杉, 雅子堀口, Valerie L. Sodi, Nishi Srivastava, Vikas Kumar, Safoora Deihimi, Shane W. O’Brien, Suraj Peri, Gina Mantia-Smaldone, Angela Jain, Ryan M. Winters, Kathy Q. Cai, Jonathan Chernoff, Denise C. Connolly, James S. Duncan	2020	19
7	Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target Molecular & Cellular Proteomics ·Alison Kurimchak, Vikas Kumar, Tisya Kusuma Rini, 雅子堀口, Nishi Srivastava, 谢光耀, Suraj Peri, Kathy Q. Cai, Gina Mantia-Smaldone, James S. Duncan	2020	18
8	Leukotriene Synthesis Is Critical for Medulloblastoma Progression Clinical Cancer Research ·Fang Du, Praveen Kumar Etta, Eric H. Lee, Yuan Wang, Shengyou Liao, Yan Cheng, Li Zhang, Chaonan Zheng, Suraj Peri, Kathy Q. Cai, Jessica M.Y. Ng, Tom Curran, Peng Li, Zeng-jie Yang	2019	12
9	Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models Cancer Research ·茂登代梶谷, Eleonora Sementino, Yuwaraj Kadariya, Craig W. Menges, Mitchell Cheung, Yinfei Tan, Kathy Q. Cai, Michael Slifker, Suraj Peri, Andres J. Klein–Szanto, Frank J. Rauscher, Joseph R. Testa	2019	41
10	Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma Clinical Cancer Research ·Renata E. Gordon, Li Zhang, Suraj Peri, Yin‐Ming Kuo, Fang Du, Brian L. Egleston, Jessica M.Y. Ng, Andrew J. Andrews, Igor Astsaturov, Tom Curran, Zeng-jie Yang	2018	53
11	Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas Journal of Cellular Physiology ·Eleonora Sementino, Craig W. Menges, Yuwaraj Kadariya, Suraj Peri, Jinfei Xu, Zemin Liu, Thitipan Somtawin, Kathy Q. Cai, Frank J. Rauscher, Andres J. Klein–Szanto, Joseph R. Testa	2018	23
12	Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling Neoplasia ·Elizabeth Matthew, Zhaohai Yang, Suraj Peri, Mark Andrake, Roland L. Dunbrack, Eric A. Ross, Wafik S. El‐Deiry	2018	16
13	Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes Molecular Cancer Therapeutics ·Lauren S. Fink, Alexander Beatty, Karthik Devarajan, Suraj Peri, Jeffrey R. Peterson	2014	11
14	NF-κB Inhibition by Bortezomib Permits IFN-γ–Activated RIP1 Kinase–Dependent Necrosis in Renal Cell Carcinoma Molecular Cancer Therapeutics ·Roshan J. Thapa, Peirong Chen, Mitchell Cheung, Shoko Nogusa, Jianming Pei, Suraj Peri, Joseph R. Testa, Siddharth Balachandran	2013	19
15	Anti-CD70 Immunocytokines for Exploitation of Interferon-γ-Induced RIP1-Dependent Necrosis in Renal Cell Carcinoma PLoS ONE ·Peirong Chen, Shoko Nogusa, Roshan J. Thapa, Calvin Shaller, Heidi H. Simmons, Suraj Peri, Gregory P. Adams, Siddharth Balachandran	2013	12
16	The challenge of cholestatic pruritus. PubMed ·Léonard Caquot, Suraj Peri, Ronald P.J. Oude Elferink, Ulrich Beuers	2012	13
17	Defining the genomic signature of the parous breast BMC Medical Genomics ·Suraj Peri, Ricardo López de Cicco, Julia Santucci-Pereira, Michael Slifker, Eric A. Ross, Irma H. Russo, Patrícia A. Russo, Alan A. Arslan, Ilana Belitskaya‐Lévy, Anne Zeleniuch‐Jacquotte, Pál Bordás, Per Lenner, Gurbet Yeliz Turan, Yelena Afanasyeva, Robert Johansson, Fathima Sheriff, Göran Hallmans, Paolo Toniolo, José Russo	2012	51
18	Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 or BRCA2 Mutations Cancer Prevention Research ·Alfonso Bellacosa, Andrew K. Godwin, Suraj Peri, Karthik Devarajan, Elena Caretti, Lisa Vanderveer, Betsy Bove, Carolyn Slater, Yan Zhou, Mary B. Daly, 苏彬陈勇, Kerry S. Campbell, Émmanuelle Nicolas, Anthony T. Yeung, Margie L. Clapper, James A. Crowell, Henry T. Lynch, Eric A. Ross, Levy Kopelovich, Alfred G. Knudson	2010	41
19	Early Changes in Gene Expression Induced by Tobacco Smoke: Evidence for the Importance of Estrogen within Lung Tissue Cancer Prevention Research ·Sibele I. Meireles, Артем Романович Чемаров, Roberto Hirata, Suraj Peri, Karthik Devarajan, Michael Slifker, Stacy Mosier, Jing Peng, Manicka V. Vadhanam, Harrell E. Hurst, E. Jordão Neves, Luiz F. L. Reis, C. Gary Gairola, Ramesh C. Gupta, Margie L. Clapper	2010	49
20	Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers Cancer Biology & Therapy ·Manoj Kumar Kashyap, Arivusudar Marimuthu, Harrys K.C. Jacob, Suraj Peri, Shivakumar Keerthikumar, Thottethodi Subrahmanya Keshava Prasad, Riaz Mahmood, Sudha Rao, Prathibha Ranganathan, Dr.V. Nandini, M. Vijayakumar, K. V. Veerendra Kumar, Elizabeth A. Montgomery, Rekha V. Kumar, Akhilesh Pandey	2009	94

About Suraj Peri

Suraj Peri is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Aging, having authored 63 papers that have together received 3.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), RNA and protein synthesis mechanisms (5 papers), Epigenetics and DNA Methylation (5 papers), interferon and immune responses (4 papers), Cancer Risks and Factors (4 papers), Genomics and Phylogenetic Studies (4 papers), Cancer-related gene regulation (4 papers) and Advanced Proteomics Techniques and Applications (4 papers). The work is most often cited by research in Hepatology (314 citations), Immunology (628 citations), Molecular Biology (2.0k citations), Cancer Research (383 citations) and Epidemiology (541 citations). Suraj Peri has collaborated with scholars based in United States, Denmark and India. Frequent co-authors include Akhilesh Pandey, Siddharth Balachandran, Hanno Steen, Michael Slifker, Ting Zhang, Chaoran Yin, Paul G. Thomas, Yan Xu, Jeremy Chase Crawford and Samuel Litwin. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Cancer Prevention Research, PLoS ONE and Trends in Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact